Position: Chief Executive Officer (since 1 January 2019)

Number of shares in Navamedic ASA: 794,928  

Year of birth: 1966

 Experience: 

Before assuming her current role, Gamborg Andreassen served as Chair of the Board at Navamedic ASA from June to December 2018. Prior to joining Navamedic, she held several senior leadership positions at Weifa ASA from 2012 to 2018, including CEO. Her career also includes leadership roles at Kemetyl and Orkla. Gamborg Andreassen has previously served on the board of directors at Observe Medical, Questback and Vistin Pharma. 

Education: 

Gamborg Andreassen holds a master’s degree (MSc) in Business Strategy & Marketing from the University of Wisconsin at Madison and a BBA from Handelsakademiet/Oslo Business School.